- Home
- FFWM vs MREO Comparison
FFWM vs MREO Comparison
Compare FFWM & MREO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FFWM
- MREO
- Stock Information
- Founded
- FFWM 1990
- MREO 2015
- Country
- FFWM United States
- MREO United Kingdom
- Employees
- FFWM N/A
- MREO N/A
- Industry
- FFWM Major Banks
- MREO Biotechnology: Pharmaceutical Preparations
- Sector
- FFWM Finance
- MREO Health Care
- Exchange
- FFWM Nasdaq
- MREO Nasdaq
- Market Cap
- FFWM 668.6M
- MREO 577.6M
- IPO Year
- FFWM 2014
- MREO N/A
- Fundamental
- Price
- FFWM $7.71
- MREO $3.53
- Analyst Decision
- FFWM Buy
- MREO Strong Buy
- Analyst Count
- FFWM 5
- MREO 4
- Target Price
- FFWM $7.80
- MREO $7.50
- AVG Volume (30 Days)
- FFWM 647.4K
- MREO 690.6K
- Earning Date
- FFWM 10-29-2024
- MREO 11-12-2024
- Dividend Yield
- FFWM 0.52%
- MREO N/A
- EPS Growth
- FFWM N/A
- MREO N/A
- EPS
- FFWM N/A
- MREO N/A
- Revenue
- FFWM $108,182,000.00
- MREO $1,000,000.00
- Revenue This Year
- FFWM N/A
- MREO $16.39
- Revenue Next Year
- FFWM $31.32
- MREO $9.44
- P/E Ratio
- FFWM N/A
- MREO N/A
- Revenue Growth
- FFWM N/A
- MREO N/A
- 52 Week Low
- FFWM $4.84
- MREO $1.86
- 52 Week High
- FFWM $11.47
- MREO $5.02
- Technical
- Relative Strength Index (RSI)
- FFWM 55.59
- MREO 28.70
- Support Level
- FFWM $6.40
- MREO $4.05
- Resistance Level
- FFWM $8.34
- MREO $4.40
- Average True Range (ATR)
- FFWM 0.36
- MREO 0.19
- MACD
- FFWM 0.05
- MREO -0.06
- Stochastic Oscillator
- FFWM 67.27
- MREO 2.81
About FFWM First Foundation Inc.
First Foundation Inc is a financial services company. It is engaged in providing investment management and financial planning services for high-net-worth individuals, retirement plans, charitable institutions, and private foundations. The company focuses on segments namely Banking and Wealth Management. It also offers loans to individuals and entities that own and operate multifamily residential and commercial real estate properties as well as business banking products and services to small to moderate-sized businesses, professional firms, and consumer banking products and services to individuals.
About MREO Mereo BioPharma Group plc
Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of innovative therapeutics for rare diseases. The Company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).